======= SPC25 =======
== Gene Information ==
* **Official Symbol**: SPC25
* **Official Name**: SPC25 component of NDC80 kinetochore complex
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57405|57405]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9HBM1|Q9HBM1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SPC25&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SPC25|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609395|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Acts as a component of the essential kinetochore- associated NDC80 complex, which is required for chromosome segregation and spindle checkpoint activity (PubMed:14699129, PubMed:14738735). Required for kinetochore integrity and the organization of stable microtubule binding sites in the outer plate of the kinetochore (PubMed:14738735, PubMed:14699129). The NDC80 complex synergistically enhances the affinity of the SKA1 complex for microtubules and may allow the NDC80 complex to track depolymerizing microtubules (PubMed:23085020). {ECO:0000269|PubMed:14699129, ECO:0000269|PubMed:14738735, ECO:0000269|PubMed:23085020}.
|Spc7|
|Spindle Spc25|
|Ndc80 complex|
|mitotic spindle organization|
|condensed chromosome kinetochore|
|microtubule cytoskeleton organization involved in mitosis|
|spindle organization|
|chromosome segregation|
|microtubule cytoskeleton organization|
|cell division|
|mitotic cell cycle process|
|microtubule-based process|
|mitotic cell cycle|
|cell cycle process|
|cytoskeleton organization|
|cell cycle|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-1.77|
|[[:results:exp447|Amiloride 100μM R08 exp447]]|-1.74|
|[[:results:exp261|ABT-702 5μM R06 exp261]]|1.74|
|[[:results:exp336|Asunaprenir 3μM R07 exp336]]|1.88|
|[[:results:exp343|Centrinone 0.5μM R07 exp343]]|2.15|
|[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.42|
|[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|2.46|
|[[:results:exp293|Myriocin 25μM R06 exp293]]|2.49|
|[[:results:exp406|Thalidomide 20μM R07 exp406]]|2.51|
^Gene^Correlation^
|[[:human genes:c:casc5|CASC5]]|0.416|
Global Fraction of Cell Lines Where Essential: 682/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|27/28|
|blood|27/28|
|bone|25/26|
|breast|30/33|
|central nervous system|50/56|
|cervix|4/4|
|colorectal|16/17|
|esophagus|10/13|
|fibroblast|1/1|
|gastric|13/16|
|kidney|17/21|
|liver|19/20|
|lung|70/75|
|lymphocyte|15/16|
|ovary|22/26|
|pancreas|24/24|
|peripheral nervous system|14/16|
|plasma cell|13/15|
|prostate|1/1|
|skin|23/24|
|soft tissue|8/9|
|thyroid|2/2|
|upper aerodigestive|21/22|
|urinary tract|27/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1078
* **Expression level (log2 read counts)**: 4.87
{{:chemogenomics:nalm6 dist.png?nolink |}}